FDA Inspection 1026240 — Kyowa Hakko Bio Co. Ltd.
The FDA completed an inspection of Kyowa Hakko Bio Co. Ltd. on Sep 15, 2017 in Ube. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 15, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ube (Japan)